annual SGA:
$0.00-$47.28M(-100.00%)Summary
- As of today (September 14, 2025), SPRY annual SGA is $0.00, with the most recent change of -$47.28 million (-100.00%) on December 31, 2024.
- During the last 3 years, SPRY annual SGA has fallen by -$4.69 million (-100.00%).
- SPRY annual SGA is now -100.00% below its all-time high of $47.28 million, reached on December 31, 2023.
Performance
SPRY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$41.10M(-100.00%)Summary
- As of today (September 14, 2025), SPRY quarterly SGA is $0.00, with the most recent change of -$41.10 million (-100.00%) on June 30, 2025.
- Over the past year, SPRY quarterly SGA has dropped by -$8.94 million (-100.00%).
- SPRY quarterly SGA is now -100.00% below its all-time high of $41.10 million, reached on March 31, 2025.
Performance
SPRY quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$655.92M-$48.02M(-7.90%)Summary
- As of today (September 14, 2025), SPRY TTM SGA is -$655.92 million, with the most recent change of -$48.02 million (-7.90%) on June 30, 2025.
- Over the past year, SPRY TTM SGA has dropped by -$694.62 million (-1794.88%).
- SPRY TTM SGA is now -928.29% below its all-time high of -$63.79 million.
Performance
SPRY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SPRY Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -1794.9% |
| 3 y3 years | -100.0% | -100.0% | -3468.3% |
| 5 y5 years | -100.0% | -100.0% | -10000.0% |
SPRY Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -101.6% | +25.1% |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -578.1% | +25.1% |
| alltime | all time | -100.0% | at low | -100.0% | at low | -928.3% | +25.1% |
SPRY Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $60.38M(-12.9%) |
| Mar 2025 | - | $41.10M(>+9900.0%) | $69.33M(+91.6%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $36.18M(-15.9%) |
| Sep 2024 | - | $19.28M(+115.6%) | $43.01M(+11.1%) |
| Jun 2024 | - | $8.94M(+12.4%) | $38.70M(-10.1%) |
| Mar 2024 | - | $7.96M(+16.7%) | $43.06M(-8.9%) |
| Dec 2023 | $47.28M(+156.2%) | $6.82M(-54.4%) | $47.28M(+16.9%) |
| Sep 2023 | - | $14.98M(+12.6%) | $40.46M(+42.4%) |
| Jun 2023 | - | $13.30M(+9.2%) | $28.41M(+61.8%) |
| Mar 2023 | - | $12.18M(+316.3%) | $17.57M(+14.4%) |
| Dec 2022 | $18.46M | - | - |
| Sep 2022 | - | $2.93M(+19.0%) | $15.36M(-21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $2.46M(+5.1%) | $19.47M(-18.1%) |
| Mar 2022 | - | $2.34M(-69.4%) | $23.78M(-15.3%) |
| Dec 2021 | $4.69M(-43.8%) | - | - |
| Dec 2021 | - | $7.64M(+8.5%) | $28.08M(+13.6%) |
| Sep 2021 | - | $7.04M(+4.1%) | $24.71M(+39.8%) |
| Jun 2021 | - | $6.76M(+1.7%) | $17.67M(+44.3%) |
| Mar 2021 | - | $6.65M(+55.9%) | $12.25M(+90.5%) |
| Dec 2020 | $8.34M(+225.6%) | $4.26M(+218.9%) | $6.43M(+127.7%) |
| Jun 2020 | - | $1.34M(+61.5%) | $2.82M(+90.0%) |
| Mar 2020 | - | $828.00K(+25.8%) | $1.49M(+125.8%) |
| Dec 2019 | $2.56M(-27.1%) | $658.00K | $658.00K |
| Dec 2018 | $3.52M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is ARS Pharmaceuticals, Inc. annual SGA?
The current annual SGA of SPRY is $0.00
What is the all time high annual SGA for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual SGA is $47.28M
What is ARS Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, SPRY annual SGA has changed by -$47.28M (-100.00%)
What is ARS Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of SPRY is $0.00
What is the all time high quarterly SGA for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly SGA is $41.10M
What is ARS Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, SPRY quarterly SGA has changed by -$8.94M (-100.00%)
What is ARS Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of SPRY is -$655.92M
What is the all time high TTM SGA for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM SGA is -$63.79M
What is ARS Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, SPRY TTM SGA has changed by -$694.62M (-1794.88%)